Inpatient and Outpatient Orderable
IgVH Mutation Analysis by NGS Build info
Synonyms |
|
||||||||||||||||
Short Name |
IGVH MUTATION ANALYSIS (CLL PROGNOSIS) |
||||||||||||||||
Procedure Master Number |
LAB10976 |
||||||||||||||||
Procedure ID |
|||||||||||||||||
Clinical Info |
Prognostic marker for patients with CLL. Hypermutated IgVH is a favorable prognostic indicator in CLL. |
||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||
Specimen Types |
Blood | ||||||||||||||||
Container |
Lavender Top tube |
||||||||||||||||
Collection Instructions |
Container/Tube: Lavender Top tube |
||||||||||||||||
Transport Instructions |
Refrigerated |
||||||||||||||||
Specimen Stability |
|||||||||||||||||
Methodology |
Fluorescense |
||||||||||||||||
Days Performed |
TAT: 4 Weeks |
||||||||||||||||
Performing Laboratory |
BioReference Laboratories-GenPath |
||||||||||||||||
CPT |
81263 |
||||||||||||||||
PDM |
1659924 | ||||||||||||||||
Only Orderable at Locations: |
Orderable Everywhere | ||||||||||||||||
Results |
|